Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
EKF Diagnostics Holdings plc is a global medical diagnostics company focused on the development, manufacture, and distribution of point-of-care (POC) and central laboratory diagnostic products. Their portfolio includes tests for hemoglobin, HbA1c, glucose, lactate, and other biomarkers, catering to diverse healthcare settings such as hospitals, clinics, and laboratories. EKF aims to improve patient outcomes and healthcare efficiency by providing reliable and accessible diagnostic tools worldwide, with a strong presence in areas like diabetes care, hematology, and sports medicine.
Serves as the central hub for corporate management, strategic decision-making, finance, global sales and marketing oversight, and administrative functions for EKF's worldwide operations.
Modern office facilities designed to support global operations. Specific architectural details are not widely publicized, but the location facilitates access to UK talent and infrastructure.
EKF fosters a collaborative and innovative work environment, encouraging employees to contribute to the development of cutting-edge diagnostic solutions. The culture emphasizes quality, customer focus, and scientific excellence.
The Penarth headquarters is strategically important for overseeing EKF's global operations, R&D direction, and maintaining its position in the European and international diagnostics markets.
EKF Diagnostics operates globally with manufacturing sites in the UK, Germany, Ireland, and the USA. The company distributes its products in more than 100 countries directly and through a robust network of distributors. Key functions supported globally include R&D, manufacturing, sales, marketing, technical support, and distribution of point-of-care devices, central lab reagents and analyzers, and life science products.
Avon House, 19 Stanwell Road
Penarth
Vale of Glamorgan
United Kingdom
Address: Ebendorfer Chaussee 3, 39179 Barleben, Germany
Supports EKF's strong presence in the European diagnostics market, focusing on development and production of core analyzer technologies and consumables. Facilitates distribution and technical support across Europe.
Address: 1261 North Main Street, Boerne, Texas 78006, USA
Serves as a primary manufacturing and distribution hub for North and South American markets, supporting EKF's Stanbio product line and expanding its footprint in the region's healthcare sector.
Address: 1121 E. South Street, South Bend, IN 46615, USA
Supports EKF's expansion into the life sciences and molecular diagnostics market in North America, providing specialized products and laboratory services.
Address: Steinkuhlenwuhne 2, 39128 Magdeburg, Germany
Complements the Barleben facility, strengthening EKF's manufacturing and R&D capabilities within Germany and for the broader European market.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, EKF Diagnostics' leadership includes:
EKF Diagnostics has been backed by several prominent investors over the years, including:
In the last 12-18 months, EKF Diagnostics has seen key leadership changes. Notably, Marc Davies was appointed Chief Financial Officer in July 2023, succeeding Adam Curtis. This change aligns with the company's ongoing strategic initiatives and refreshment of its executive team.
Discover the tools EKF Diagnostics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
EKF Diagnostics primarily utilizes the email format of [first initial][last name]@ekfdiagnostics.com (e.g., jsmith@ekfdiagnostics.com). This is the most common and reliable structure for employee email addresses at the company.
firstinitiallast@ekfdiagnostics.com
Format
msalter@ekfdiagnostics.com
Example
90%
Success rate
Proactive Investors • March 19, 2024
EKF Diagnostics reported a strong start to 2024, with positive trading momentum across its business units. The company highlighted growth in its point-of-care and life sciences divisions, and expressed confidence in meeting market expectations for the year....more
EKF Diagnostics (Press Release) • January 23, 2024
EKF Diagnostics received FDA 510(k) clearance and CLIA waiver for its EKF Link system, a digital connectivity solution for its DiaSpect Tm hemoglobin analyzer, enhancing data management capabilities for point-of-care testing....more
EKF Diagnostics IR / London Stock Exchange RNS • September 27, 2023
EKF Diagnostics announced its interim financial results, reporting revenues of £26.1m for H1 2023. The company highlighted progress in its core Point-of-Care business and ongoing investments in Life Sciences, while navigating post-COVID market adjustments....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including EKF Diagnostics, are just a search away.